Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies
Robert Roskoski
Topics & Concepts
KinasePhosphatidylinositolP110αReceptor tyrosine kinaseBiochemistryChemistryCell biologyAKT2PhosphorylationBiologyAKT1Protein kinase BPI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingCancer Mechanisms and Therapy